Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ABOULKER JP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 32 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rabaud, C; Charreau, I; Izard, S; Raffi, F; Meiffredy, V; Leport, C; Guillemin, F; Yeni, P; Aboulker, JP
      Adverse reactions to cotrimoxazole in HIV-infected patients: Predictive factors and subsequent HIV disease progression

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    2. Aboulker, JP; Babiker, A; Darbyshire, JH; Debre, M; Giaquinto, C; Gibb, DM; Harper, L; Newberry, A; Saidi, Y; Levy, J; Della Negra, M; Forbes, J; Vaudry, W; Mechinaud, F; Nicolas, J; Wahn, V; Dammann, C; Notheis, G; Hinkelmann, B; Butler, K; Giaquinto, C; De Manzini, A; Mazza, A; Duse, M; Loy, A; Plebani, A; Castelli-Gattinara, G; Cellini, M; Palomba, E; Caselli, D; Guarino, A; Osimani, P; Scherpbier, H; Delgado, A; Gomez, ID; Lecuona, JE; Pena, MJM; Baselga, C; Leal, JAL; Amador, JTR; Canosa, C; Sierra, AM; Calavia, LC; Rodrigo, C; Guasch, CF; Bohlin, A; Nadal, D; Mok, J; Lyall, H; Novelli, V; Sharland, M; Sloper, K
      Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial

      ARCHIVES OF DISEASE IN CHILDHOOD
    3. Aboulker, JP
      Viral load in treatment with antiretroviral therapy and interleukin 2

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    4. Descamps, D; Flandre, P; Calvez, V; Peytavin, G; Meiffredy, V; Collin, G; Delaugerre, C; Robert-Delmas, S; Bazin, B; Aboulker, JP; Pialoux, G; Raffi, F; Brun-Vezinet, F
      Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    5. Masquelier, B; Descamps, D; Carriere, I; Ferchal, F; Collin, G; Denayrolles, M; Ruffault, A; Chanzy, B; Izopet, J; Buffet-Janvresse, C; Schmitt, MP; Race, E; Fleury, HJA; Aboulker, JP; Yeni, P; Brun-Vezinet, F
      Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the Delta lamivudine roll-over study

      ANTIVIRAL THERAPY
    6. Salmon-Ceron, D; Fillet, AM; Aboulker, JP; Gerard, L; Houhou, N; Carriere, I; Ostinelli, J; Vilde, JL; Brun-Vezinet, F; Leport, C
      Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patientswith persistent CMV viremia

      CLINICAL INFECTIOUS DISEASES
    7. Raffi, F; Franck, J; Pelloux, H; Derouin, F; Reliquet, V; Ambroise-Thomas, P; Aboulker, JP; Leport, C; Dumon, H
      Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitis

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    8. Aboulker, JP; Babiker, AG; Flandre, P; Gazzard, B; Loveday, C; Nunn, AJ; Goudsmit, J; Huraux, JM; van der Noorda, J; Weiss, R; Boucher, C; Schurrman, R; Brun-Vezinet, F; Descamps, D; Jeffries, D; Tedder, R; Weber, J; Darbyshire, JH; Reiss, P; Weverling, G
      An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome

      AIDS
    9. Zou, WP; Foussat, A; Houhou, S; Durand-Gasselin, I; Dulioust, A; Bouchet, L; Galanaud, P; Levy, Y; Emilie, D; Aboulker, JP; Capitant, C; Boue, F; Bouvet, E; Karmochkinc, M; Kazatchkine, M; Oksenhendler, E; Viard, JP; Weiss, L; Yeni, P; Delfraissy, JF; Goujard, C; Jarrousse, B; Lepeu, G; Cartier, F; Bazin, C; Six, M; Gastaut, JA; Seligmann, M; Herrerra, A; Maral, J
      Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2

      AIDS
    10. Aboulker, JP; Babiker, AG; Brun-Vezinet, F; Darbyshire, JH; Flandre, P; Gazzard, B; Nunn, AJ; Goodall, R; Aber, V; Bragman, K; Breckenridge, AM; Carbon, C; Charreau, I; Chene, G; Collis, P; Cooper, D; Dormont, J; Fiddian, P; Flepp, M; Goebel, FD; Hooker, M; Lange, J; Luthy, R; Peto, TEA; Reiss, P; Seligmann, M; Stone, AB; Thomis, J; Vella, S; Walckenaer, G; Warrell, D; Weller, IVD; Wilber, R; Yeni, P; Yeo, J; Withnall, R; Goudsmit, J; Huraux, JM; van der Noorda, J; Weiss, R; Boucher, C; Schuurman, R; Descamps, D; Jeffries, D; Tedder, R; Weber, J; Krzyanowski, C; Weverling, G
      HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study

      AIDS
    11. Aboulker, JP
      Drug-resistant genotyping in HIV-1 therapy

      LANCET
    12. Levy, Y; Capitant, C; Houhou, S; Carriere, I; Viard, JP; Goujard, C; Gastaut, JA; Oksenhendler, E; Boumsell, L; Gomard, E; Rabian, C; Weiss, L; Guillet, JG; Delfraissy, JF; Aboulker, JP; Seligmann, M
      Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial

      LANCET
    13. Parazzini, F; Ricci, E; Di Cintio, E; Chiaffarino, F; Pardi, G; Parazzini, F; Bortolus, R; D'Oro, LC; Biraghi, P; Bucceri, A; Ravizza, M; Grossi, E; Muggiasca, ML; Tibaldi, C; Prati, A; Iasci, A; Aronica, E; Ceccarelli, E; Frigerio, L; Borlone, P; Stagnizza, M; Agnoletto, V; Tognoni, G; Lazzrin, A; Massobrio, M; Garzetti, GG; Ciavattini, A; Mosca, S; Greco, P; Vimercati, A; Guerra, B; Bianchi, S; Bovicelli, L; Prati, E; Innocenti, TA; Fiscella, A; Bucceri, A; Grossi, E; Rossi, G; Rancilio, L; Ferraris, G; Vignali, M; Muggiasca, ML; Semprini, AE; Ravizza, M; Castagna, C; Della Torre, M; Martinelli, P; Sansone, M; di Lenardo, L; Russolo, A; Rubino, E; Lo Bue, G; Maccabruni, A; Arlandi, L; Citernesi, A; Villa, P; Mancuso, S; Pachi, A; Scaravelli, G; Tibaldi, C; Benedetto, C; Ziarati, N; Gabiano, C; Alberico, S; Franchi, M; Zanconato, G; Fedele, L; Newell, ML; Bailey, A; Peckham, C; Darbyshire, J; Sanchez, E; Semprini, AE; Leyes, M; Ciria, LM; Coll, O; Fortuny, C; Bogunya, JM; Paya, A; Mur, A; Casellas, M; Lain, J; Anzen, B; Lindgren, S; Rudin, C; Irion, O; Bewley, S; Kennedy, J; Mandelbrot, L; Bazin, B; Aboulker, JP; Crenn-Hebert, C; Tudal, CF; Bech, A; Lobut, R; Chemla, JP; Milliez, J; Courpotin, C; Mandelbrot, L; Firtion, G; Benifla, JL; Ottenwalter, A; Vilmer, E; Hocke, C; Douard, D; Berrebi, A; Tricoire, J; Pauly, I; Le Lorier, B; Bongain, A; Monpoux, F; Cravello, L; Perrimond, H; Newell, ML; Darbyshire, J; Peckham, C; Coll, O; Sanchez, E; Mandelbrot, L; Aboulker, JP; Bazin, B; Blanche, S
      Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

      LANCET
    14. PIKETTY C; CASTIEL P; BELEC L; BATISSE D; MOHAMED AS; GILQUIN J; GONZALEZCANALI G; JAYLE D; KARMOCHKINE M; WEISS L; ABOULKER JP; KAZATCHKINE MD
      DISCREPANT RESPONSES TO TRIPLE COMBINATION ANTIRETROVIRAL THERAPY IN ADVANCED HIV DISEASE

      AIDS
    15. ABOULKER JP; BABIKER A; CARRIERE I; DARBYSHIRE JH; DEBRE M; GIAQUINTO C; GIBB DM; HARPER L; NEWBERRY A; SAIDI Y; TUDORWILLIAMS G
      A RANDOMIZED DOUBLE-BLIND TRIAL OF THE ADDITION OF LAMIVUDINE OR MATCHING PLACEBO TO CURRENT NUCLEOSIDE ANALOG REVERSE-TRANSCRIPTASE INHIBITOR THERAPY IN HIV-INFECTED CHILDREN - THE PENTA-4 TRIAL

      AIDS
    16. ABOULKER JP; BABIKER AG; CLUMECK N; COOPER DA; DARBYSHIRE JH; DORMONT J; GATELL J; GOEBEL F; LAURIAN Y; MANNUCCI P; MATHIESEN L; PETO TEA; REISS P; SANDSTROM E; SAVIDGE G; SELIGMANN M; SMITH D; STINGL G; VEENSTRA J; WELLER IVD; YEO J; LAFON E; MCCORMACK S; SWART AM; WITHNALL R
      LONG-TERM FOLLOW-UP OF RANDOMIZED TRIALS OF IMMEDIATE VERSUS DEFERREDZIDOVUDINE IN SYMPTOM-FREE HIV-INFECTION

      AIDS
    17. CHENE G; MORLAT P; LEPORT C; HAFNER R; DEQUAE L; CHARREAU I; ABOULKER JP; LUFT B; AUBERTIN J; VILDE JL; SALAMON R
      INTENTION-TO-TREAT VS. ON-TREATMENT ANALYSES OF CLINICAL-TRIAL DATA -EXPERIENCE FROM A STUDY OF PYRIMETHAMINE IN THE PRIMARY PROPHYLAXIS OF TOXOPLASMOSIS IN HIV-INFECTED PATIENTS

      Controlled clinical trials
    18. PIALOUX G; RAFFI F; BRUNVEZINET F; MEIFFREDY V; FLANDRE P; GASTAUT JA; DELLAMONICA P; YENI P; DELFRAISSY JF; ABOULKER JP
      A RANDOMIZED TRIAL OF 3 MAINTENANCE REGIMENS GIVEN AFTER 3 MONTHS OF INDUCTION THERAPY WITH ZIDOVUDINE, LAMIVUDINE, AND INDINAVIR IN PREVIOUSLY UNTREATED HIV-1-INFECTED PATIENTS

      The New England journal of medicine
    19. COULAUD JP; GOUGEON ML; GOMARD E; DESCAMPS D; LEBON P; ABOULKER JP; BIZZINI B; ZAGURY D
      A PLACEBO-CONTROLLED CLINICAL-PHASE-I TRIAL WITH COMBINED ANTI-HIV-1 AND ANTI-INTERFERON-ALPHA IMMUNIZATION

      AIDS
    20. RAFFI F; ABOULKER JP; MICHELET C; RELIQUET V; PELLOUX H; HUART A; POIZOTMARTIN I; MORLAT P; DUPAS B; MUSSINI JM; LEPORT C; ALLEGRE T; AUBERTIN J; BEYLOT J; CANTON P; AMBROISETHOMAS P; MICOUD M; PEYRAMOND D; TREPO C; GASTAUT JA; JANBON F; BARRIER JH; LITOUX P; DELLAMONICA P; CARBON C; COULAUD JP; VACHON F; VILDE JL; SICARD D; COMPAGNUCCI A; MARSAL L; MODAI J; SELIGMANN M; LANG JM; LAFEUILLADE A
      A PROSPECTIVE-STUDY OF CRITERIA FOR THE DIAGNOSIS OF TOXOPLASMIC ENCEPHALITIS IN 186 AIDS PATIENTS

      AIDS
    21. PELLOUX H; DUPOUYCAMET J; DEROUIN F; ABOULKER JP; RAFFI F
      A MULTICENTER PROSPECTIVE-STUDY FOR THE POLYMERASE CHAIN-REACTION DETECTION OF TOXOPLASMA-GONDII DNA IN BLOOD-SAMPLES FROM 186 AIDS PATIENTS WITH SUSPECTED TOXOPLASMIC ENCEPHALITIS

      AIDS
    22. BRUNVEZINET F; BOUCHER C; LOVEDAY C; DESCAMPS D; FAUVEAU V; IZOPET J; JEFFRIES D; KAYE S; KRZYANOWSKI C; NUNN A; SCHUURMAN R; SEIGNEURIN JM; TAMALET C; TEDDER R; WEBER J; WEVERLING GJ; ABER V; ABOULKER JP; BABIKER AG; BRAGMAN K; BRECKENRIDGE AM; CARBON C; CHARREAU I; CHENE G; COLLIS P; COOPER D; DARBYSHIRE JH; DORMONT J; FIDDIAN P; FLEPP M; GAZZARD B; GOEBEL FD; HOOKER M; LANGE J; LUTHY R; PETO TEA; REISS P; SELIGMANN M; STONE AB; THOMIS J; VELLA S; WALCKENAER G; WARRELL D; WELLER IVD; WILBER R; YENI P; YEO J; WITHNALL R; BABIKER A; BLOCH J; POUCHER C; DARBYSHIRE J; GOUDSMIT J; HURAUX JM; VANDERNOORDAA J; WEISS R; WEVERLING G
      HIV-1 VIRAL LOAD, PHENOTYPE, AND RESISTANCE IN A SUBSET OF DRUG-NAIVEPARTICIPANTS FROM THE DELTA-TRIAL

      Lancet
    23. JOLY V; AUBRY P; NDAYIRAGIDE A; CARRIERE I; KAWA E; MLIKACABANNE N; ABOULKER JP; COULAUD JP; LAROUZE B; YENI P
      RANDOMIZED COMPARISON OF AMPHOTERICIN-B DEOXYCHOLATE DISSOLVED IN DEXTROSE OR INTRALIPID FOR THE TREATMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS

      Clinical infectious diseases
    24. ABOULKER JP
      THE PLACE OF THE PROTEASE INHIBITORS IN ANTIRETROVIRAL COMBINATION THERAPY

      Current opinion in infectious diseases
    25. CARBON C; WARRELL D; ABOULKER JP; COOPER DA; DARBYSHIRE JH; DORMONT J; FLEPP M; LANGE J; LEVY JP; MATHIESEN L; PETO TEA; PINCHING AJ; REISS P; SCHWARTZ D; SELIGMANN M; STONE A; THOMIS J; WITHNALL R; BARKER S; FRISSEN PJ; DEJONG MD; LOEWENTHAL M; TOURNERIE C; VALENTINE C; ABER V; BABIKER AG; CHARREAU I; THAKRAR B; VRAY M; LUTHY R
      THE ALPHA-TRIAL - EUROPEAN AUSTRALIAN RANDOMIZED DOUBLE-BLIND TRIAL OF 2 DOSES OF DIDANOSINE IN ZIDOVUDINE-INTOLERANT PATIENTS WITH SYMPTOMATIC HIV DISEASE/

      AIDS
    26. ABER V; ABOULKER JP; BABIKER AG; BRAGMAN K; BRECKENRIDGE AM; CARBON C; CHARREAU I; CHENE G; COLLIS P; COOPER D; DARBYSHIRE JH; DORMONT J; FIDDIAN P; FLEPP M; GAZZARD B; GOEBEL FD; HOOKER M; LANGE J; LUTHY R; PETO TEA; REISS P; SELIGMANN M; STONE AB; THOMIS J; VELLA S; WALCKENAER G; WARRELL D; WELLER IVD; WILBER R; YENI P; YEO J; WITHNALL R
      DELTA - A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL COMPARING COMBINATIONS OF ZIDOVUDINE PLUS DIDANOSINE OR ZALCITABINE WITH ZIDOVUDINE ALONE IN HIV-INFECTED INDIVIDUALS

      Lancet
    27. SALMONCERON C; FONTBONNE A; SABA J; MAY T; RAFFI F; CHIDIAC C; PATEY O; ABOULKER JP; SCHWARTZ D; VILDE JL
      LOWER SURVIVAL IN AIDS PATIENTS RECEIVING DAPSONE COMPARED WITH AEROSOLIZED PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA (VOL 172, PG 656, 1995)

      The Journal of infectious diseases
    28. GIBB DM; DARBYSHIRE JH; DEBRE M; GIAQUINTO C; ABOULKER JP; MARTINEZ M; TUDORWILLIAMS G
      TREATMENT OF CHILDREN WITH HIV-INFECTION

      Lancet
    29. SALMONCERON D; FONTBONNE A; SABA J; MAY T; RAFFI F; CHIDIAC C; PATEY O; ABOULKER JP; SCHWARTZ D; VILDE JL
      LOWER SURVIVAL IN AIDS PATIENTS RECEIVING DAPSONE COMPARED WITH AEROSOLIZED PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA

      The Journal of infectious diseases
    30. OKSENHENDLER E; CHARREAU I; TOURNERIE C; AZIHARY M; CARBON C; ABOULKER JP
      TOXOPLASMA-GONDII INFECTION IN ADVANCED HIV-INFECTION

      AIDS
    31. ABOULKER JP; BABIKER AG; DARBYSHIRE JH; DORMONT J; PETO TEA; SELIGMANN M; SWART AM; WELLER IVD
      CONCORDE TRIAL OF IMMEDIATE VERSUS DEFERRED ZIDOVUDINE - REPLY

      Lancet
    32. SELIGMANN M; WARRELL DA; ABOULKER JP; CARBON C; DARBYSHIRE JH; DORMONT J; ESCHWEGE E; GIRLING DJ; JAMES DR; LEVY JP; PETO TEA; SCHWARZ D; STONE AB; WELLER IVD; WITHNALL R; GELMON K; LAFON E; SWART AM; ABER VR; BABIKER AG; LHORO S; NUNN AJ; VRAY M
      CONCORDE - MRC ANRS RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL OF IMMEDIATE AND DEFERRED ZIDOVUDINE IN SYMPTOM-FREE HIV-INFECTION/

      Lancet


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 12:57:51